PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.

Abstract

PD-0332991 has antiproliferative activity in RCC cell lines, and molecular markers predict for sensitivity to this agent.